EP3250237
HEMIASTERLIN AFLEIÐUR TIL SAMTENGINGAR OG MEÐFERÐAR
Status:
EP Einkaleyfi fallið úr gildiEP appl. date:
29.1.2016EP published:
26.5.2021EP application number:
16705387.5
EP translation filed:
12.7.2021Grant published:
15.8.2021EPO information:
European Patent Register
Max expiry date:
28.1.2036Expiry date:
28.1.2025
Title:
HEMIASTERLIN DERIVATIVES FOR CONJUGATION AND THERAPY
Timeline
Today
29.1.2016EP application
26.5.2021EP Publication
12.7.2021Translation submitted
15.8.2021Registration published
28.1.2025Expires
Owner
Name:
Sutro Biopharma, Inc.Address:
111 Oyster Point Blvd., South San Francisco, California 94080, US
Inventor
Name:
KLINE, ToniAddress:
South San Francisco, California 94080, US
Name:
YIN, QunAddress:
South San Francisco, California 94080, US
Name:
BAJJURI, KrishnaAddress:
South San Francisco, California 94080, US
Agent
Name:
G.H. Sigurgeirsson ehf.Address:
Borgartúni 26, 105, Reykjavík,
Priority
Number:
201562110390 PDate:
30.1.2015Country:
US
Classification
Categories:
C07K 5/065, C07K 5/02, A61P 35/00, A61K 47/68, A61K 38/00
Annual fees
Number
Paid
Expires
Payer
Number: 7
Paid: 7.12.2021
Expires: 28.1.2023
Payer: Árnason Faktor ehf.
Number: 8
Paid: 13.12.2022
Expires: 28.1.2024
Payer: Árnason Faktor ehf.
Number: 9
Paid: 18.12.2023
Expires: 28.1.2025
Payer: Árnason Faktor ehf.